EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study

Calin Burciu iD, Roxana Sirli iD, Renata Bende, Deiana Vuletici, Bogdan Miutescu iD, Tudor Moga iD, Felix Bende iD, Alina Popescu, Ioan Sporea, Oana Koppandi, Eftimie Miutescu, Dana Iovanescu und 1 weitere

Medicina · 2024

DOI: 10.3390/medicina60040552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Calin Burciu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Paraneoplastic Syndromes, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Liver cancer poses a significant global health threat, ranking among the top three causes of cancer-related deaths. Patients with hepatocellular carcinoma (HCC) often present with symptoms associated with neoplasms or unusual clinical features such as paraneoplastic syndromes (PNS), including hypoglycemia, hypercholesterolemia, thrombocytosis, and erythrocytosis. Our study aimed to investigate the prevalence, clinical characteristics, and survival outcomes associated with PNS in HCC patients and assess each PNS’s impact on patient survival. Materials and Methods: We conducted a retrospective analysis of PNS clinical features and survival among consecutive HCC patients diagnosed at our department over seven years, comparing them with HCC patients without PNS. The study involved a retrospective data evaluation from 378 patients diagnosed with HCC between January 2016 and October 2023.

Results

We obtained a PNS prevalence of 25.7%, with paraneoplastic hypercholesterolemia at 10.9%, hypoglycemia at 6.9%, erythrocytosis at 4.5%, and thrombocytosis at 3.4%. Patients with PNS tended to be younger and predominantly male. Multivariate analysis revealed a strong correlation between PNS and levels of alpha-fetoprotein and tumor size, with diabetes also showing a significant statistical association (p < 0.05). Subgroup analysis based on specific paraneoplastic syndromes demonstrated shorter survival in patients with PNS, albeit without significant statistical differences, except for hypoglycemia (p < 0.0001). Matched analysis indicated a shorter survival rate for patients with PNS, although no significant statistical differences were observed.

Conclusions

PNS are frequently observed in HCC cases and are associated with unfavorable prognoses and decreased survival rates due to their correlation with increased tumor burdens. However, they do not independently predict poor survival. The impact of individual PNS on HCC prognosis varies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularParaneoplastic SyndromesLiver NeoplasmsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedPrevalenceAdultSurvival AnalysisHypercholesterolemiaHypoglycemiaPolycythemiaAged, 80 and overThrombocytosis

Stichwörter der Autor:innen

hepatocellular carcinomaparaneoplastic syndromessurvival

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Advanced Regional Research Center in Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
  • Department of Gastroenterology, Faculty of Medicine, Pharmacy and Dental Medicine, "Vasile Goldis" West University of Arad, 310414 Arad, Romania.

ORCID-Profile: Calin Burciu, Roxana Sirli, Bogdan Miutescu, Tudor Moga, Felix Bende

Förderung

  • Victor Babes University of Medicine and Pharmacy Timisoara

Zitieren

APA

Burciu, C., Sirli, R., Bende, R., Vuletici, D., Miutescu, B., Moga, T., Bende, F., Popescu, A., Sporea, I., Koppandi, O., Miutescu, E., Iovanescu, D., & Danila, M. (2024). Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study. Medicina. https://doi.org/10.3390/medicina60040552

Vancouver

Burciu C, Sirli R, Bende R, Vuletici D, Miutescu B, Moga T, et al. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study. Medicina. 2024. doi:10.3390/medicina60040552

BibTeX
@article{Burciu2024,
  author = {Burciu, Calin and Sirli, Roxana and Bende, Renata and Vuletici, Deiana and Miutescu, Bogdan and Moga, Tudor and Bende, Felix and Popescu, Alina and Sporea, Ioan and Koppandi, Oana and Miutescu, Eftimie and Iovanescu, Dana and Danila, Mirela},
  title = {Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60040552}
}
Kostenlos starten →